Aphria Inc. (TSX: APH and US OTC: APHQF) today announced that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart. -
Articles
Veritas Pharma Inc.’s (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Cannevert Subsidiary Inks Material Transfer Agreement with the Institute for Medical Cannabis of Puerto Rico
Emerging pharmaceutical and IP development company Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) today announced that its research arm, Cannevert Therapeutics Ltd. (“CTL”), has signed a Material Transfer Agreement with the Institute for Medical Cannabis Corporation of Puerto Rico.
Purified Cannabinoids Open New Opportunities in Pain Management
As consumer acceptance continues to propel demand to unprecedented levels, companies such as InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) are making waves in the advancement of cannabinoid compounds as a medical solution in pain management and other indications.-
SinglePoint, Inc. (SING) Enters Joint Venture Agreement with Smart Cannabis Corp. (SCNA)
SinglePoint (OTC: SING) this morning said it has entered a joint venture relationship with Smart Cannabis Corp. (OTC: SCNA) to license and market Smart Cannabis’ SMART app.
B.C. releases first decisions on cannabis regulation after public engagement
After considering input from 48,951 British Columbians, and submissions from 141 local and Indigenous governments and a range of other interested stakeholders, the Province has announced a number of key decisions related to the anticipated legalization of non-medical cannabis in July 2018.-
Marijuana Company of America, Inc. (MCOA) Further Strengthens Positioning in the Cannabis and Industrial Hemp CBD Markets
Marijuana Company of America (OTC: MCOA) has established a commanding presence in the cannabis and industrial hemp cannabidiol (“CBD”) markets, as well as the related services supply chain, creating an umbrella over a diverse portfolio of cannabis- and hemp-based companies.
Spectrum Cannabis Denmark Announces Forty Thousand Square Metre Medical Cannabis Facility in Odense
Hi-tech Greenhouse Positions Spectrum Cannabis as European Cannabis Leader & Odense as Major European Medical Cannabis Centre-
Aurora Cannabis Completes Larssen and H2 Biopharma Acquisitions
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that, further to its press releases of November 23, 2017, the Company has completed the acquisitions of Larssen Ltd, a globally leading greenhouse engineering and design consultancy, and that of H2 Biopharma, a late-stage ACMPR applicant based in Quebec.-
Aurora Cannabis Increases Ownership Interest in Radient Technologies
Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies Inc. ("Radient) (TSX-V: RTI) today announced that further to the investor rights agreement between both companies, as announced on November 6, 2017, Aurora will make a further investment in Radient for a total of $12 million
Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Provides 2018 Strategy Update Regarding Growth Plans
Licensed Canadian cannabis cultivation company Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) this morning provided an update regarding its growth plans for 2018.
Zynerba Pharmaceuticals Announces New ZYN002 Data from STAR 1 and STAR 2 Studies in Patients with Focal Seizures at the 2017 Annual Meeting of the American Epilepsy Society (AES)
Clinically Meaningful Median Reduction in Seizures Compared to Baseline of 48% to 65% Achieved with Continued ZYN002 Treatment in STAR 2 Extension Study. Data Help Clarify Protocol Design for Planned ZYN002 Phase 2 Trial in Epilepsy -
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress
GW Pharmaceuticals plc (Nasdaq:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces financial results for the fourth quarter and year-ended 30 September 2017
Aurora Cannabis Still Committed to Cannimed Takeover Bid
Following the November 28, 2017 CanniMed Therapeutics Inc. (TSX: CMED) announcement that it has unilaterally adopted a shareholders' rights plan in response to the compelling offer made by Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) to CanniMed's shareholders, Aurora provides the following initial response.
Maricann Group Inc. Files Third Quarter Financial Results, Updates Ongoing German License Progress and Distribution Efforts
Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) filed its financial statements for the 3 months ending September 30, 2017, with results that were consistent with expectations.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Announces Stock, Option and Warrant Transactions
Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, this morning announced various stock, option and warrant transactions.